TickerLeague

Revenue for Revolution Medicines (RVMD)

According to Revolution Medicines's latest reported financial statements, the company's current revenue (TTM) is $0 USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$0

YoY change

N/A

5Y CAGR

-100.0%

Peak year (2019)

$50.04M

Cumulative revenue

$189.54M

Revenue history chart for Revolution Medicines (RVMD) from 2017 to 2025

Revenue history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedRevenueYoYYoY change
2025$0$0
2024$0-100.0%-$11.58M
2023$11.58M-67.3%-$23.80M
2022$35.38M+20.4%+$5.99M
2021$29.39M-31.6%-$13.59M
2020$42.98M-14.1%-$7.06M
2019$50.04M+148.2%+$29.88M
2018$20.16M+$20.16M
2017$0

Revenue values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Revolution Medicines (RVMD) most recent annual revenue stands at $0 (2025).

Across 2020–2025 (5 years), Revolution Medicines revenue produced a CAGR of -100.0% – with a net decline across the window.

Revolution Medicines revenue plunged from $50.04M in 2019 to $0 in 2025, a 100.0% drawdown.

$50.04M stands as the all-time-high annual revenue, posted in 2019, against a low of $0 during 2017.

Among 8 Healthcare peers, Revolution Medicines (RVMD) ranks 9th; the peer median for revenue is $65.05B.

Revolution Medicines Revenue by Year

Revolution Medicines Revenue 2025: $0

Revolution Medicines revenue in 2025 was $0.

Revolution Medicines Revenue 2024: $0

Revolution Medicines revenue in 2024 was $0, plunged 100.0% below 2023.

Revolution Medicines Revenue 2023: $11.58M

Revolution Medicines revenue in 2023 was $11.58M, plunged 67.3% below 2022.

Revolution Medicines Revenue 2022: $35.38M

Revolution Medicines revenue in 2022 was $35.38M, grew 20.4% from 2021.

Revolution Medicines Revenue 2021: $29.39M

Revolution Medicines revenue in 2021 was $29.39M.

See more financial history for Revolution Medicines (RVMD).

Sector peers — Revenue

Companies in the same sector as Revolution Medicines, ranked by their latest revenue.

CompanyRevenueSector
UnitedHealth Group (UNH)$447.57BHealthcare
Novo Nordisk (NVO)$309.06BHealthcare
Johnson & Johnson (JNJ)$94.19BHealthcare
Eli Lilly (LLY)$65.18BHealthcare
Merck & Co. (MRK)$64.93BHealthcare
AbbVie (ABBV)$61.16BHealthcare
AstraZeneca (AZN)$58.74BHealthcare
Amgen (AMGN)$36.74BHealthcare

Frequently asked questions

What is Revolution Medicines's revenue?

Latest reported revenue for Revolution Medicines (RVMD) is $0 (period ending March 31, 2026).

What is the long-term growth rate of Revolution Medicines revenue?

Revolution Medicines (RVMD) revenue compound annual growth rate is -100.0% over the most recent 5 years available.

When did Revolution Medicines revenue hit its highest annual value?

Revolution Medicines revenue reached its highest annual value of $50.04M in 2019.

What was Revolution Medicines revenue in 2024?

Revolution Medicines (RVMD) revenue in 2024 was $0.

What was Revolution Medicines revenue in 2025?

Revolution Medicines (RVMD) revenue in 2025 was $0.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.